Forte Biosciences, Inc.
FBRX
$6.17
-$0.15-2.37%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 256.69% | -33.21% | -19.53% | -18.00% | -19.62% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 156.55% | 14.56% | 9.09% | -20.44% | 26.00% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 22.63% | -12.46% | 34.33% | 41.21% | 75.53% |
Total Current Assets | 247.22% | -31.28% | -18.38% | -17.81% | -18.63% |
|
|||||
Total Current Assets | 247.22% | -31.28% | -18.38% | -17.81% | -18.63% |
Net Property, Plant & Equipment | -10.47% | -10.42% | -9.43% | -2.75% | 11.22% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -28.13% | -29.15% | -33.74% | -24.82% | -19.88% |
Total Assets | 243.03% | -31.18% | -18.55% | -17.86% | -18.59% |
|
|||||
Total Accounts Payable | -5.43% | -2.20% | 213.06% | 18.33% | -73.40% |
Total Accrued Expenses | 22.83% | -10.96% | 133.27% | -26.54% | 5.90% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 5.84% | -5.89% | 173.62% | -9.11% | -50.93% |
|
|||||
Total Current Liabilities | 5.84% | -5.89% | 173.62% | -9.11% | -50.93% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 5.84% | -5.89% | 173.62% | -9.11% | -50.93% |
|
|||||
Common Stock & APIC | 32.17% | 0.51% | 0.51% | 0.52% | 0.50% |
Retained Earnings | -4.87% | -6.06% | -9.93% | -6.26% | -5.21% |
Treasury Stock & Other | 1,000.00% | 114.29% | -250.00% | -150.00% | 180.00% |
Total Common Equity | 460.32% | -44.78% | -40.87% | -18.77% | -12.61% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 460.32% | -44.78% | -40.87% | -18.77% | -12.61% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 460.32% | -44.78% | -40.87% | -18.77% | -12.61% |
|